A Randomised Phase II Trial of Osimertinib with or without Stereotactic Radiosurgery for EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) With Brain Metastases

Parakh, Sagun (Primary Chief Investigator (PCI))

Medicine Monash Health

Project: Research

Project Description

NMA HREC Reference Number: HREC/18/MH/53 (ERM Project ID 39668)
NMA SSA Reference Number: SSA/39668/MonH-2019-166033(v1)
Monash Health Ref: RES-19-0000-138X

Status	Active
Effective start/end date	20/03/19 → 19/03/24

View all

View less

Keywords

clinical trial
treatment efficacy
lung cancer
phase 2 trial
clinical trial
treatment efficacy
lung cancer
phase 2 trial
clinical trial
treatment efficacy
lung cancer
phase 2 trial